Arzeda
Seattle, Washington, United States · Biotechnology, Other, research · 64 employees
Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications.
Funding history
- Series seed — $4.5M — Sep 2025
- Funding Round — $37.9M — Aug 2024
- Funding Round — $14.9M — Nov 2023
- Series series b — $33.0M — Mar 2022
- Funding Round — $25.7M — Jul 2021
Recent signals
- Sep 11, 2025: Raised $4.5M in Series seed
- Nov 07, 2024: Launched Arzeda Announces Major Production Milestone for ProSweet RebM™ and Expands Production to Meet Demand
- Sep 17, 2024: Arzeda Secures Funding to Accelerate Commercialization Efforts and Expand Production Capacity
- Aug 08, 2024: Raised $37.9M
- Nov 13, 2023: Raised $14.9M
- Mar 30, 2022: Raised $33.0M in Series series b
- Jul 22, 2021: Raised $25.7M
- Nov 10, 2020: Raised $3.3M in Series seed
See plans & pricing → Track Arzeda’s funding, hiring, and signals — with verified contacts — on Fundz.